SYDNEY: Aumake Ltd. (ASX: AUK), a distributor of Australian and New Zealand consumer brands in Asia, said Thursday that unaudited full-year sales rose more than 50% to over A$39 million, as improving trade ties between China and Australia boosted demand.
Chairman Anthony Noble attributed the growth to favorable geopolitical shifts and Aumake’s strategic position in cross-border retail, saying, “Few companies stand better positioned to capitalise on the increased focus on trade between the two countries.”
The company’s FY25 revenue, up from A$25.87 million a year earlier, reflects renewed momentum across Aumake’s B2B and B2C channels in China.
In FY26, Aumake will pursue a revamped strategy aimed at reducing costs and expanding brand presence. The firm plans to simplify its business structure, explore new sales channels—including Pilot Zone distribution into China hospital pharmacies—and activate international sales of its own branded products such as BioBasics through its NewEra / ZoomCoo partnership.
The restructure divides Aumake into two business units focused on brand incubation and targeted acquisition. The company said the move will provide greater transparency for shareholders and sharpen focus on profitability and market agility.
Aumake partners with global brands including Danone and Kabrita, and is positioning itself as a leading conduit for high-quality consumer products entering the China market.